Abstract
Copy-number variants of the CYFIP1 gene in humans have been linked to autism spectrum disorders (ASD) and schizophrenia (SCZ), two neuropsychiatric disorders characterized by defects in brain connectivity. Here, we show that CYFIP1 plays an important role in brain functional connectivity and callosal functions. We find that Cyfip1-heterozygous mice have reduced functional connectivity and defects in white matter architecture, similar to phenotypes found in patients with ASD, SCZ and other neuropsychiatric disorders. Cyfip1-deficient mice also present decreased myelination in the callosal axons, altered presynaptic function, and impaired bilateral connectivity. Finally, Cyfip1 deficiency leads to abnormalities in motor coordination, sensorimotor gating and sensory perception, which are also known neuropsychiatric disorder-related symptoms. These results show that Cyfip1 haploinsufficiency compromises brain connectivity and function, which might explain its genetic association to neuropsychiatric disorders.
Original language | English |
---|---|
Article number | 3454 |
Pages (from-to) | 1-13 |
Number of pages | 13 |
Journal | Nature Communications |
Volume | 10 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Aug 2019 |
Funding
We thank Joanna Viguie, Karin Jonckers and Jonathan Royaert for valuable technical assistance and Annick Crevoisier and Eef Lemmens for excellent administrative support. We are grateful to Annette Gärtner, Eleonora Rosina, Laura D’Andrea, Esperanza Fer-nández, Vittoria Mariano, and all the members of the Bagni laboratory for helping during the development of this project with scientific discussions. We would like to thank Graham Knott and Gadea Mata for their assistance in imaging and image processing of EM and immunohistochemistry data, Wim Vanduffel (KU Leuven) for supporting Marcelo Armendáriz and Egbert Welker for scientific discussions. We are grateful to Muna Hilal for helping in setting up the MEA system and to Leonardo Restivo (NEU-ROBAU) for advice on behavioural assays. We also would like to thank Romano Regazzi, Beat M. Riederer and Matthijs Verhage for providing us antibodies during the course of the study. This work was supported by KU Leuven funds (OTF), FWO G088415N, SNSF NCCR Synapsy 51NF40-158776, SNSF 310030-182651, Novartis Foundation for Medical-Biological Research and Canton Etat de Vaud. N.D.I. was recipient of an FWO aspirant fellowship. D.S. is recipient of an FWO (12R1119N) and IWT (13160) fellowships.
Funders | Funder number |
---|---|
Novartis Foundation for Medical-Biological Research and Canton Etat de Vaud | |
Fonds Wetenschappelijk Onderzoek | 51NF40-158776, G088415N, SNSF 310030-182651 |
KU Leuven |